Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.93034 | 39 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.89536 | 39 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.885 | 39 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.83853 | 39 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.84177 | 39 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.95882 | 38 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.92734 | 38 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.8762 | 39 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.86449 | 39 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.8868 | 39 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.88371 | 39 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.86412 | 39 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.89059 | 39 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.88992 | 39 |